Literature DB >> 23471213

Adverse Effects and Toxicity of the Atypical Antipsychotics: What is Important for the Pediatric Emergency Medicine Practitioner.

J J Rasimas1, Erica L Liebelt.   

Abstract

Medications are being used with greater frequency to address pediatric mental health problems, and in recent years atypical antipsychotic (AAP) prescriptions have increased more than any other class. Acute care practitioners must be aware of the pharmacology of AAPs and the conditions, on- and off-label, for which they are prescribed. This involves identifying and managing side effects that manifest both mentally and physically. Although "atypicality" confers a lower risk of movement side effects compared to conventional agents, children are more sensitive than adults to extrapyramidal reactions. Like adults, they also may present with toxic sedation, confusion, cardiovascular dysfunction, and metabolic derangements. Evaluation and management of these toxicities requires an index of suspicion, a careful symptom and medication history, physical examination, and targeted interventions. This review is designed to orient the emergency practitioner to the challenging task of recognizing and treating adverse effects related to acute and chronic atypical antipsychotic exposure in children.

Entities:  

Keywords:  Atypical antipsychotics; QTc prolongation; Torsades de pointes; extrapyramidal syndromes (EPS); neuroleptic malignant syndrome

Year:  2012        PMID: 23471213      PMCID: PMC3587131          DOI: 10.1016/j.cpem.2012.09.005

Source DB:  PubMed          Journal:  Clin Pediatr Emerg Med        ISSN: 1522-8401


  28 in total

1.  Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.

Authors:  S Kapur; P Seeman
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Authors:  Gabriele Masi; Francesca Liboni
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 3.  Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tamara Pringsheim; Darren Lam; Heidi Ching; Scott Patten
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  Olanzapine overdose mimicking opioid intoxication.

Authors:  G F O'Malley; S Seifert; K Heard; F Daly; R C Dart
Journal:  Ann Emerg Med       Date:  1999-08       Impact factor: 5.721

5.  Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison.

Authors:  S Kumra; J A Frazier; L K Jacobsen; K McKenna; C T Gordon; M C Lenane; S D Hamburger; A K Smith; K E Albus; J Alaghband-Rad; J L Rapoport
Journal:  Arch Gen Psychiatry       Date:  1996-12

6.  Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.

Authors:  Gerhard Gründer; Christine Fellows; Hildegard Janouschek; Tanja Veselinovic; Christian Boy; Anno Bröcheler; Katrin M Kirschbaum; Sandra Hellmann; Katja M Spreckelmeyer; Christoph Hiemke; Frank Rösch; Wolfgang M Schaefer; Ingo Vernaleken
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

Review 7.  A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.

Authors:  Hock Heng Tan; Jason Hoppe; Kennon Heard
Journal:  Am J Emerg Med       Date:  2009-06       Impact factor: 2.469

8.  Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Authors:  Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

Review 9.  One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review.

Authors:  Christoph U Correll; John M Kane
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-10       Impact factor: 2.576

10.  Pediatric ziprasidone overdose.

Authors:  Charles J Fasano; Gerald F O'Malley; Claudia Lares; Adam K Rowden
Journal:  Pediatr Emerg Care       Date:  2009-04       Impact factor: 1.454

View more
  7 in total

Review 1.  Treatment of neurolept-induced tardive dyskinesia.

Authors:  Stacey K Jankelowitz
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570

2.  Olanzapine-induced Cataract in a Teenage Girl.

Authors:  Chang Zhen Lim; Khairy Shamel Sonny Teo; Evelyn Tai
Journal:  Cureus       Date:  2018-04-30

3.  Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada.

Authors:  Jean Lachaine; Leila Ben Amor; Tamara Pringsheim; James Burns; Judy van Stralen
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-09-17       Impact factor: 2.576

4.  The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial.

Authors:  Dora Koller; Miriam Saiz-Rodríguez; Pablo Zubiaur; Dolores Ochoa; Susana Almenara; Manuel Román; Daniel Romero-Palacián; Alejandro de Miguel-Cáceres; Samuel Martín; Marcos Navares-Gómez; Gina Mejía; Aneta Wojnicz; Francisco Abad-Santos
Journal:  Br J Clin Pharmacol       Date:  2020-04-27       Impact factor: 4.335

5.  Effectiveness and Adverse Effects of Risperidone in Children with Autism Spectrum Disorder in a Naturalistic Clinical Setting at a University Hospital in Oman.

Authors:  Salim Al-Huseini; Ali Al-Barhoumi; Miad Al-Balushi; Amira Al-Hosni; Tamadhir Al-Mahrouqi; Balqees Al-Mahrizi; Sanjay Jaju; Hassan Mirza
Journal:  Autism Res Treat       Date:  2022-01-31

6.  Association of Treatment With Antipsychotics, Antidepressants, or Both With Movement Disorders and Seizures Among Children and Adolescents With Depression in Korea.

Authors:  Soo Min Jeon; Hae-Young Park; Susan Park; Un Sun Chung; Jin-Won Kwon
Journal:  JAMA Netw Open       Date:  2022-04-01

Review 7.  Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists.

Authors:  Simone Pisano; Gennaro Catone; Stefania Veltri; Valentina Lanzara; Marco Pozzi; Emilio Clementi; Raffaella Iuliano; Maria Pia Riccio; Sonia Radice; Massimo Molteni; Annalisa Capuano; Antonella Gritti; Giangennaro Coppola; Annarita Milone; Carmela Bravaccio; Gabriele Masi
Journal:  Ital J Pediatr       Date:  2016-05-21       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.